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RESUMEN
Objetivo. El objetivo del presente estudio es diseñar y evaluar las microesferas mucoadherentes de libe-
ración controlada para uso oral.
Material y métodos. Las microesferas de rosiglitazona maleato con una capa de alginato y polímeros 
mucoadherentes de carboximetilcelulosa de sodio, carbopol 934P e hidroxipropilmetilcelulosa fueron 
elaboradas por un proceso de gelificación iónica de orificio. Las microesferas se evaluaron mediante 
rayos infrarrojos con transformado de Fourier, se estudio la morfología, el tamaño de partícula, las pro-
piedades «micromeritics», el porcentaje de eficacia de entrapamiento, la prueba in vitro de «wash-off» y 
estudios in vitro de liberación.
Resultados. Las microesferas que resultaban eran esféricas y de flujo libre. La eficiencia de captura fue 
de 68,2 a 85,6%. Las microesferas exhibieron buena propiedad mucoadherentes en el ensayo in vitro de 
lavado. La liberación lde las microesferas mucoadherentes de Rosiglitazona fue lento y se prolongado 
más de 12 h dependiendo de la composición de la capa.
Conclusiones. Las microesferas preparadas con mucoadherentes son convenientes para la liberación 
oral controlada de rosiglitazona maleato y así ayudar en el tratamiento de la diabetes mellitus tipo II.
Palabras clave: microesferas mucoadherentes, rosiglitazona maleato, liberación controlada.
ABSTRACT
Aim: The objective of the present study is to design and evaluate mucoadhesive microspheres for oral 
controlled release.
Materials and Method: Rosiglitazone maleate microspheres with a coat consisting of alginate and a mu-
coadhesive polymer sodium carboxymethylcellulose, carbopol 934P and hydroxypropylmethylcellulose 
were prepared by an orifice-ionic gelation process. The microspheres were evaluated for FTIR studies, 
morphology, particle size, micromeritic properties, percentage entrapment efficiency, in-vitro wash-off 
test and in-vitro release studies.
Results: The resulting microspheres were spherical and free flowing. The percent entrapment efficiency 
was 68.2 to 85.6%. The microspheres exhibited good mucoadhesive property in the in vitro wash-off test. 
Rosiglitazone release from these mucoadhesive microspheres was slow and extended over 12 h duration 
of time depending on the composition of coat.
Conclusions: The prepared mucoadhesive microspheres are thus suitable for oral controlled release of 
Rosiglitazone maleate and thereby help in the management of type II diabetes mellitus.
Keywords: mucoadhesive microspheres, rosiglitazone maleate, sustained release.
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INTRODUCTION
Diabetes mellitus (DM) is a group of metabolic diseases 
characterized by hyperglycemia, hypertriglyceridaemia 
and hypercholesterolaemia, resulting from defects in insu-
lin secretion or action or both1. Several attempts have been 
proposed to improve oral bioavailability, among them mi-
croencapsulation represents a promising concept2. Micro-
encapsulation has been employed to sustain drug release, 
providing a long lasting and more reliable release with gas-
trointestinal (GI) irritation reduced or eliminated3.
Bioadhesive delivery of drugs has gained prominence in re-
cent times as a means of drug administration. The intimate 
contact of the mucoadhesive polymer with the mucous sur-
face can result in an increased drug retention time, increas-
ing bioavailability and increasing contact time between 
drug and mucosa4,5,6. When the mucoadhesive dosage form 
is administered in either tablet or capsule form, they may 
or may not adhere to the mucous surface due to the weight 
of the dosage form and the vigorous movement of the GI 
tract, resulting in a large variation. However, mucoadhe-
sive microspheres have some advantages. These include a 
light weight and a smaller dose variation due to the large 
number of microspheres administered7.
Rosiglitazone maleate (RSZ) is an antidiabetic drug for type 
II diabetes that improves insulin sensitivity in muscle and 
adipose tissues through activation of peroxidase prolifer-
ator-activated γ receptor (PPAR γ) that are involved in the 
transcription of insulin responsive genes responsible for 
glucose production, transport, and utilization8. The aim of 
the present work is to characterize the rosiglitazone micro-
spheres with biological half-life of 3-4 h and to evaluate the 
usefulness and feasibility of these microspheres for orally 
administered drug delivery system.
MATERIALS AND METHODS
Materials
Rosiglitazone (RSZ) was obtained from Zydus Cadila, 
Ahmedabad, India. Sodium alginate (CDH, New Delhi), 
Calcium chloride (Qualigens, Mumbai), Hydroxypropyl-
methylcellulose (HPMC), K4M, Sodium carboxymethylcel-
lulose (SCMC) and carbopol-934P (CP) were procured from 
Central Drug House, Mumbai. All other reagents used 
were of analytical grade and purchased from their respec-
tive commercial sources.
Methods
Preparation of Microspheres
Rosiglitazone microspheres were prepared by ionotropic 
gelation method9 employing sodium alginate in combina-
tion with various polymers using sodium CMC, HPMC 
and carbopol 934P in different ratios (1:1, 1:9 and 9:1). So-
dium alginate (1.0 g) was dissolved in purified water (50 
ml) to form a homogeneous polymer solution with 1.0 g 
of each polymer. The drug RSZ (2.0 g) was added to the 
polymer solution and the resulting dispersion was added 
manually drop wise into 10% w/v of calcium chloride solu-
tion (about 40 ml) through a syringe with a needle size no. 
18. The added droplets were retained in the calcium chlo-
ride solution for 30 min to complete the curing reaction. 
The microspheres were collected by decantation, and the 
product thus separated was washed repeatedly with water 
and dried at 45° C for 12 hrs.
FT-IR Study
The Fourier transform infrared (FT-IR) spectra of pure drug 
(RSZ) and drug-polymer loaded microspheres were ob-
tained using a Perkin-Elmer spectroscope. About 2-3 mg of 
samples were mixed with dried KBr of equal weight and 
compressed to form KBr disks. The samples were scanned 
from 400 to 4000 cm-1.
Morphology and Particle size
Shape and surface morphology of microspheres were stud-
ied using Scanning Electron Microscope (SEM LEO 430, 
Leo Electron Microscopy Ltd., England). For determination 
of surface characteristics all the microspheres were coated 
uniformly with gold palladium by using sputter coater for 
5 to 7 minutes, after fixing the sample in individual steps. 
All samples of microspheres were then randomly examined 
for surface morphology at different magnification ranges.
Particle size of the microcapsules was evaluated using opti-
cal microscopy method10. Approximately 100 microspheres 
were counted for particle size determination using a cali-
brated optical microscope (Magnus MLX-DX). The experi-
ments were done in triplicate (n=3) 11.
Micromeritic Properties of Microspheres
Accurately weighed microspheres were gently poured us-
ing a glass funnel into a graduated cylinder exactly to 10 ml 
mark. Initial volume was noted. Bulk density and taapped 
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density were noted using tapping method using measuring 
cylinder (of 10 ml).
Angle of repose of prepared microspheres (n=3) was deter-
mined by fixed funnel standing method. The granules were 
allowed to flow through funnel orifice on a plane paper 
kept on the horizontal surface to form a pile of granules. 
Angle of repose (θ), Hausner’s ratio (H) and Carr’s index 
(% C) were calculated to study the flow properties of micro-
spheres by using following formulas12.
where, h is height and r is radius of the pile, respectively.
where, Dt is tapped and Db is bulk density, respectively.
Percentage Entrapment efficiency
50 mg of microspheres were dispersed in 10 ml of 0.1 N 
HCl for 30 min with occasional shaking. The suspension 
was then centrifuged at 2000 rpm for 5 min and the super-
natant was kept aside. The drug concentration was deter-
mined spectrophotometrically by UV at 228 nm (Shimadzu 
Pharmspec UV-1700, Japan). The entrapment efficiency 
(n=3) was calculated by using following formula13.
where, Dcal is the calculated drug content and Dth is the 
theoretical drug content, respectively.
In-vitro wash-off test
Freshly excised pieces of intestinal mucosa (5 x 2 cm) from 
sheep were mounted onto glass slides (3 x 1 inch) with ad-
hesive material14. About 50 microspheres were spread onto 
each wet rinsed tissue specimen, and immediately thereaf-
ter the support was hung onto the arm of a U.S.P. tablet dis-
integrating test machine. By operating the disintegrating 
test machine the tissue specimen was given a slow, regular 
up and down movement in the test fluid at 37ºC contained 
in a 1 l vessel of the machine. At the end of one hr, and 
at hourly intervals up to 12 hrs, the machine was stopped 
and the number of microspheres still adhering to the tis-
sue was counted. The test was performed at both simulated 
gastric fluid (0.1 N HCl, pH 1.2) and simulated intestinal 
fluid (phosphate buffer, pH 7.4). The mucoadhesiveness of 
the microspheres were compared with microspheres of a 
nonbioadhesive material, ethylene vinyl acetate (EVA).
In-vitro drug release of microspheres
A USP XXIII basket type dissolution apparatus was used to 
study in-vitro drug release from microspheres. A weighed 
amount of microspheres (50 mg) was used for the study. 900 
ml of dissolution medium (0.1N HCl, pH 1.2) maintained at 
a temperature of 37±0.5°C and rotation speed of 100 rpm 
was used for the study15. The in-vitro release studies were 
performed for 12 h. At predetermined time intervals, 5 ml 
sample was withdrawn, passed through a 0.45 µm mem-
brane filter (Millipore). After appropriate dilutions, the 
concentration of drug in samples were analysed spectro-
photometrically at 228 nm using Shimadzu, Pharmspec 
UV-1700 series, Japan. The initial volume of dissolution 
medium was maintained by adding 5 ml of fresh dissolu-
tion medium after each withdrawal. Perfect sink conditions 
prevailed during the in-vitro drug release studies.
Statistical analysis
Experimental results were performed in triplicate (n=3) 
and expressed as mean ± S.D. One-way analysis of variance 
(ANOVA) was applied to check significant difference in 
drug release from different formulations. Differences were 
considered to be significant at P<0.05.
RESULTS AND DISCUSSION
FTIR Study
Potential chemical interaction between drug and polymer 
may change the therapeutic efficacy of the drug. To inves-
tigate the possibility of chemical interaction between drug 
and polymer, FTIR spectra of pure RGL and drug-loaded 
formulations containing different polymers were analyzed 
over the range 400-4000 cm-1. The IR spectra of pure RGL 
showed strong absorption bands attributable to carbonyl 
stretching at 1703 cm-1 and C=N stretching of pyridine moi-
ety at 1512 cm-1. FTIR spectra of the drug loaded formula-
tions displayed all the characteristic bands of drug without 
any significant spectral shift. This suggested that there was 
no potential chemical interaction between the components 
of the microspheres (Spectras not shown).
Physical characterization of microspheres
The microspheres were found to be discrete, spherical and 
free-flowing. The effects of alginate concentrations and 
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polymer ratios on the average particle size and % drug en-
trapment of microspheres are shown in Table 1. The mean 
particle size increased with increase in polymer concentra-
tion which might be due to the fact that as polymer con-
centration increases it produces a significant increase in the 
viscosity, leading to an increase of the emulsion droplet size 
and finally a higher microsphere size.
The % entrapment efficiency for the different formulations 
significantly increased with increasing polymer content 
(p<0.05). The alginate-CP microspheres (9:1) produced the 
highest % entrapment efficiency of 85.6±3.2. An increase in 
polymer concentration resulted in formation of larger mi-
crospheres entrapping greater amount of drug16.
The size of the microspheres increased with increase in the 
alginate concentration which may be due to the increase in 
viscosity, resulting in increase in droplet size during addi-
tion of the polymer dispersion to the harvesting medium. 
The SEM of prepared microspheres (F1) is shown in Figure 
1. Formation of cracks on the surface of the microspheres 
were observed which may be due to the penetration of the 
dissolution medium into the microspheres and the sub-
sequent dissolution of the drug and hence its diffusion 
through the polymer matrix.
Figure 1. SEM photograph of prepared microspheres (F1)
Table 1: Composition and evaluation of drug loaded microspheres
Code Coat composition
% entrapment 
efficiency
Particle size
Angle of 
repose
Carr’s 
index
Hausner’s ratio
F1 Alg-SCMC (1:1) 68.2±2.3 404±3.5 42°54’ 9.8 1.04
F2 Alg-SCMC (1:9) 76.4±1.6 412±5.5 42°15’ 10.2 1.08
F3 Alg-SCMC (9:1) 84.5±2.4 438±2.8 41°72’ 11.2 1.12
F4 Alg-HPMC (1:1) 71.4±1.5 426±5.2 42°24’ 10.7 1.06
F5 Alg-HPMC (1:9) 75.8±1.8 435±4.5 42°26’ 10.8 1.11
F6 Alg-HPMC (9:1) 82.2±2.1 459±3.8 41°58’ 11.5 1.14
F7 Alg-CP (1:1) 74.5±2.4 488±4.2 41°24’ 11.7 1.09
F8 Alg-CP(1:9) 78.4±1.6 500±2.8 40°68’ 12.2 1.12
F9 Alg-CP (9:1) 85.6±3.2 510±3.4 40°17’ 12.8 1.16
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Micromeritic properties of microspheres
The rheological parameters like angle of repose, tapped 
density, bulk density and packing properties (Table 1) con-
firms better flow and packing properties of the prepared 
microspheres. All the formulation showed angle of repose 
value within the range of 30° to 45° (n=3), which is an ap-
preciable limit for microspheres to show flow property 
while formulating in the dosage form.
In-vitro wash-off studies
The mucoadhesion test was performed on both simulated 
gastric pH (0.1N HCl, pH 1.2) and simulated intestinal pH 
(phosphate buffer solution, PBS, pH 6.8) for 12h. The re-
sults are given in Table 2. Ch’ng et al. (1985) observed that 
the pH of the medium was critical for the degree of hydra-
tion, swelling and mucoadhesion of the polymers17. The 
wash-off was found to be faster at intestinal pH than at gas-
tric pH. The rapid wash-off observed at simulated intesti-
nal pH 6.8 may be due to ionization of carboxyl acid group 
and other functional groups present in the polymers at this 
pH, which increases their solubility and reduces adhesive 
strength.
The adhesion time of microspheres at pH 1.2 was ranked, 
HPMC > carbopol 934P, whereas the adhesion time for 
the microspheres at pH 6.8 was ranked, carbopol 934P > 
HPMC. Poor mucoadhesion of HPMC microspheres at al-
kaline pH may be due to its non-ionic nature possessing 
low hydrogen bonding capability with mucus glycopro-
teins18. Although carbopol 934P microspheres had nega-
tive charge repulsion with mucus, numerous hydrophilic 
functional groups such as carboxyl groups in carbopol mol-
ecules could form hydrogen bonds with mucus molecules, 
thus producing some adhesive force of this polymer. The 
microspheres produced using alginate: SCMC coat did not 
adhere to the mucosa for more than 6 h showing poor mu-
coadhesion in either of the pH mediums used for the study.
Table 2: Results of in-vitro wash-off test for the prepared microspheres
Code
Percent of microspheres adhering to tissue after 12 h duration
0.1 N HCl, pH 1.2 Phosphate buffer, pH 6.8
1 2 4 6 8 12 1 2 4 6 8 12
F1 74±1.4 70±0.5 62±1.2 56±0.8 52±1.8 18±1.2 62±1.6 20±1.1 15±0.6 10±0.4 - -
F2 78±2.5 74±1.5 70±1.8 64±2.1 58±1.5 25±0.5 68±2.2 24±1.4 18±0.5 14±0.8 - -
F3 82±1.5 74±1.6 60±0.4 38±1.2 20±0.5 - 70±1.5 32±0.8 18±1.2 05±0.5 - -
F4 78±0.5 75±0.6 70±0.8 66±1.2 62±1.4 52±1.8 70±0.5 48±2.2 34±2.8 21±0.5 05±0.8 -
F5 90±2.5 84±2.4 80±1.5 76±1.2 74±0.6 72±1.8 78±1.8 60±2.1 55±1.2 42±1.7 20±0.8 04±0.2
F6 82±1.2 71±0.8 66±0.4 38±1.1 28±0.4 18±1.2 70±1.2 58±1.7 32±1.1 18±1.2 08±0.2 -
F7 80±2.2 76±1.1 70±1.4 60±2.2 55±1.1 49±0.6 72±1.4 58±0.8 62±1.1 51±2.1 32±2.1 18±2.2
F8 88±1.8 85±1.2 82±2.4 78±1.5 75±1.0 68±1.2 82±2.0 76±0.8 72±1.1 64±0.8 53±1.5 28±2.2
F9 75±2.1 62±0.8 56±0.5 42±0.6 35±1.4 28±1.2 72±1.2 57±2.1 48±1.4 37±0.8 22±1.7 10±2.2
EVA 54±1.6 40±1.8 10±1.2 - - - 52±1.0 30±1.2 06±2.2 - - -
EVA indicates ethylene vinyl acetate (non-mucoadhesive control). Values are given as mean ± S.D.
In-vitro drug release of microspheres
Solubility of RSZ depends on pH. Maximum absorption 
may be expected with increasing solubility in acid environ-
ment. It is known that microspheres constitute multiple-
unit dosage forms which have many advantages as com-
pared to tablets. They spread more evenly in the stomach 
which leads to a decreased risk of high local concentration 
and of adverse effects. Moreover, these forms are character-
ized by a high reproducibility of release due to a relatively 
large surface and a short diffusion way of the drug19.
The in-vitro release studies were carried out in 0.1 N HCl 
(pH 1.2) which indicated that there was a slow and con-
trolled release of drug for all the formulations. The drug 
release of the microspheres at 1:9 and 9:1 ratio of alginate: 
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polymers are shown in Figure 2 and 3, respectively. Drug 
release from the RSZ microspheres was slow, extended and 
dependent on the type of polymer used. The increasing or-
der of release rate observed with microspheres was Sodium 
alginate: Sodium CMC < Sodium alginate: Carbopol < So-
dium alginate: HPMC. The differences in the drug release 
characteristics of various microspheres might be due to the 
differences in the porosity of the coat formed and its solu-
bility in the dissolution fluid. Drug release from alginate-
sodium-CMC was slow and extended over a period of 12 
hr and these microcapsules were found suitable for oral 
controlled release formulations.
Figure 2: Comparative in-vitro release study of formulations 
containing 1:9 ratio of alginate and mucoadhesive polymers
Figure 3: Comparative in-vitro release study of formulations 
containing 9:1 ratio of alginate and mucoadhesive polymers
CONCLUSIONS
Mucoadhesive microspheres offer a unique carrier system 
owing to its capability to adhere to any mucosal tissue. This 
ionic orifice method produced spherical and free flowing 
microspheres. Rosiglitazone maleate release was found to 
be slow and extended period of time. The release depend-
ed on the type of polymer used. The release of drug was 
prolonged when incorporated within mucoadhesive poly-
mers. The mucoadhesive microspheres prepared by iono-
tropic gelation technique gave sustained drug release up 
to 12 h duration. Microspheres containing alginate: sodium 
CMC gave best reproducible results, would prove to be 
promising carrier for oral delivery of rosiglitazone maleate 
and thereby help in the management of type II diabetes 
mellitus.
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